相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Is COVID-19 receiving ADE from other coronaviruses?
Jason A. Tetro
MICROBES AND INFECTION (2020)
Pathogens MenTORing Macrophages and Dendritic Cells: Manipulation of mTOR and Cellular Metabolism to Promote Immune Escape
Lonneke V. Nouwen et al.
CELLS (2020)
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
Xiaobo Yang et al.
Lancet Respiratory Medicine (2020)
SARS-CoV-2: a storm is raging
Savannah F. Pedersen et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Effectiveness of convalescent plasma therapy in severe COVID-19 patients
Kai Duan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
Yeming Wang et al.
LANCET (2020)
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
David E. Gordon et al.
NATURE (2020)
Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
Yadi Zhou et al.
CELL DISCOVERY (2020)
Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection
Li Liu et al.
JCI INSIGHT (2019)
B Cell-Intrinsic mTORC1 Promotes Germinal Center-Defining Transcription Factor Gene Expression, Somatic Hypermutation, and Memory B Cell Generation in Humoral Immunity
Ariel L. Raybuck et al.
JOURNAL OF IMMUNOLOGY (2018)
Immune-suppressive effects of interleukin-6 on T-cell-mediated anti-tumor immunity
Hirotake Tsukamoto et al.
CANCER SCIENCE (2018)
mTOR Promotes Antiviral Humoral Immunity by Differentially Regulating CD4 Helper T Cell and B Cell Responses
Lilin Ye et al.
JOURNAL OF VIROLOGY (2017)
Twenty-five years of mTOR: Uncovering the link from nutrients to growth
David M. Sabatini
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Antiviral Potential of ERK/MAPK and PI3K/AKT/mTOR Signaling Modulation for Middle East Respiratory Syndrome Coronavirus Infection as Identified by Temporal Kinome Analysis
Jason Kindrachuk et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Regulation of innate immune cell function by mTOR
Thomas Weichhart et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Adjuvant Treatment With a Mammalian Target of Rapamycin Inhibitor, Sirolimus, and Steroids Improves Outcomes in Patients With Severe H1N1 Pneumonia and Acute Respiratory Failure
Chun-Hua Wang et al.
CRITICAL CARE MEDICINE (2014)
mTOR kinase inhibitors promote antibody class switching via mTORC2 inhibition
Jose J. Limon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
First infection by all four non-severe acute respiratory syndrome human coronaviruses takes place during childhood
Weimin Zhou et al.
BMC INFECTIOUS DISEASES (2013)
Sirolimus Enhances the Magnitude and Quality of Viral-Specific CD8+T-Cell Responses to Vaccinia Virus Vaccination in Rhesus Macaques
A. P. Turner et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
Prevalence of Antibodies to Four Human Coronaviruses Is Lower in Nasal Secretions than in Serum
Geoffrey J. Gorse et al.
CLINICAL AND VACCINE IMMUNOLOGY (2010)
The Multifunctional Role of mTOR in Innate Immunity: Implications for Transplant Immunity
M. D. Saeemann et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
mTOR signaling at a glance
Mathieu Laplante et al.
JOURNAL OF CELL SCIENCE (2009)
Baculovirus expression of HCoV-OC43 nucleocapsid protein and development of a Western blot assay for detection of human antibodies against HCoV-OC43
Thomas Mourez et al.
JOURNAL OF VIROLOGICAL METHODS (2007)
Anti-SARS-CoV IgG response in relation to disease severity of severe acute respiratory syndrome
N Lee et al.
JOURNAL OF CLINICAL VIROLOGY (2006)
Neutralizing antibody response and SARS severity
MS Ho et al.
EMERGING INFECTIOUS DISEASES (2005)
Use of convalescent plasma therapy in SARS patients in Hong Kong
Y Cheng et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2005)